ROSETTA RESOURCES INC. 7,000,000 Shares of Common Stock Underwriting AgreementRosetta Resources Inc. • April 23rd, 2013 • Crude petroleum & natural gas • New York
Company FiledApril 23rd, 2013 Industry JurisdictionRosetta Resources Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 7,000,000 shares of Common Stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,050,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares.” The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
KENNAMETAL INC. Underwriting AgreementKennametal Inc • November 7th, 2012 • Machine tools, metal cutting types • New York
Company FiledNovember 7th, 2012 Industry JurisdictionKennametal Inc., a Pennsylvania corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), $400,000,000 aggregate principal amount of the Company’s 2.650% Senior Notes due 2019 (the “Securities”). The Securities will be issued pursuant to (1) an Indenture dated February 14, 2012 (the “Base Indenture”) between the Company and U.S. Bank National Association, as trustee (the “Trustee”), and (2) the Second Supplemental Indenture to be dated as of the Closing Date (the “Supplemental Indenture”, and together with the Base Indenture, the “Indenture”) between the Company and the Trustee.
Affinia Group Holdings Inc. [—] Shares of Common Stock Underwriting AgreementAffinia Group Holdings Inc. • August 12th, 2010 • Motor vehicle parts & accessories • New York
Company FiledAugust 12th, 2010 Industry JurisdictionAffinia Group Holdings Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [—] shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional [—] shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
CENTRAL EUROPEAN DISTRIBUTION CORPORATION 10,250,000 Shares of Common Stock Underwriting AgreementCentral European Distribution Corp • November 24th, 2009 • Wholesale-beer, wine & distilled alcoholic beverages • New York
Company FiledNovember 24th, 2009 Industry JurisdictionCentral European Distribution Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), an aggregate of 10,250,000 shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company (the “Underwritten Shares”). In addition, the Company proposes to issue and sell to the Underwriters, at the option of the Underwriters, up to an additional 1,025,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to collectively as the “Shares.” Jefferies & Company, Inc. and UniCredit CAIB Securities UK Ltd. have agreed to act as representatives of the several Underwriters (in such capacity, the “Representatives”) in connection with the offering and sale of the Shares.
SEATTLE GENETICS, INC. 11,000,000 Shares of Common Stock Underwriting AgreementSeattle Genetics Inc /Wa • August 12th, 2009 • Biological products, (no disgnostic substances) • New York
Company FiledAugust 12th, 2009 Industry JurisdictionSeattle Genetics, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 11,000,000 shares of common stock, par value $0.001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 1,650,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
UBS SECURITIES LLC LUMINEX CORPORATION 3,500,000 Shares of Common Stock Underwriting AgreementLuminex Corp • June 25th, 2008 • Services-commercial physical & biological research • New York
Company FiledJune 25th, 2008 Industry JurisdictionLuminex Corporation, a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,500,000 shares of common stock, par value $0.001 per share (“Common Stock”), of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 525,000 shares of Common Stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are collectively herein referred to as the “Shares”. The shares of Common Stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”. The Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock. The Rights are to be issued pursuant to a Rights Agreement (the “Rights Agreement”) dated as of June 20, 2001 betw
GENOMIC HEALTH, INC. 3,000,000 Shares of Common Stock, par value $0.0001 per share Underwriting AgreementGenomic Health Inc • May 22nd, 2007 • Services-medical laboratories • New York
Company FiledMay 22nd, 2007 Industry JurisdictionGenomic Health, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 3,000,000 shares of Common Stock, par value $0.0001 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 450,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.
COINSTAR, INC. [ ] Shares of Common Stock, $0.001 par value Form of Underwriting AgreementCoinstar Inc • December 7th, 2004 • Services-personal services • New York
Company FiledDecember 7th, 2004 Industry JurisdictionCoinstar, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule 1 hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of [ ] shares of its Common Stock, par value $0.001 per share (the “Underwritten Shares”) and, for the sole purpose of covering over-allotments in connection with the sale of the Underwritten Shares, up to an additional [ ] shares of its Common Stock (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock, par value $0.001 per share of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Common Stock”. The Common Stock, including the Shares, will have attached thereto rights (the “Rights”) to purchase Series A Junior Participating Preferred Stock, par value $0.001 per share. The Rights are to be issued pursuant to a
Underwriting AgreementPolypore International, Inc. • August 6th, 2004 • Miscellaneous chemical products • New York
Company FiledAugust 6th, 2004 Industry JurisdictionPolypore International, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters listed in Schedule I hereto (the “Underwriters”), for whom you are acting as representatives (the “Representatives”), an aggregate of 20,000,000 shares of common stock, par value $0.01 per share, of the Company (the “Underwritten Shares”) and, at the option of the Underwriters, up to an additional 3,000,000 shares of common stock of the Company (the “Option Shares”). The Underwritten Shares and the Option Shares are herein referred to as the “Shares”. The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are herein referred to as the “Stock”.